DD274053A5 - Verfahren zur Produktion eines menschlichen, einkettigen Plasminogenaktivators - Google Patents

Verfahren zur Produktion eines menschlichen, einkettigen Plasminogenaktivators Download PDF

Info

Publication number
DD274053A5
DD274053A5 DD31480088A DD31480088A DD274053A5 DD 274053 A5 DD274053 A5 DD 274053A5 DD 31480088 A DD31480088 A DD 31480088A DD 31480088 A DD31480088 A DD 31480088A DD 274053 A5 DD274053 A5 DD 274053A5
Authority
DD
German Democratic Republic
Prior art keywords
leu
giy
ser
lys
thr
Prior art date
Application number
DD31480088A
Other languages
German (de)
English (en)
Inventor
Bernd Meyhack
Jutta Heim
Rolf Buergi
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878709081A external-priority patent/GB8709081D0/en
Priority claimed from IE329987A external-priority patent/IE81116B1/en
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of DD274053A5 publication Critical patent/DD274053A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405—Glucanases
    • C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
    • C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6424—Serine endopeptidases (3.4.21)
    • C12N9/6456—Plasminogen activators
    • C12N9/6462—Plasminogen activators u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21073—Serine endopeptidases (3.4.21) u-Plasminogen activator (3.4.21.73), i.e. urokinase
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DD31480088A 1987-04-15 1988-04-15 Verfahren zur Produktion eines menschlichen, einkettigen Plasminogenaktivators DD274053A5 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB878709081A GB8709081D0 (en) 1987-04-15 1987-04-15 Production of proteins
GB878714059A GB8714059D0 (en) 1987-04-15 1987-06-16 Production of proteins
IE329987A IE81116B1 (en) 1986-12-05 1987-12-04 Hybrid plasminogen activators

Publications (1)

Publication Number Publication Date
DD274053A5 true DD274053A5 (de) 1989-12-06

Family

ID=27263391

Family Applications (1)

Application Number Title Priority Date Filing Date
DD31480088A DD274053A5 (de) 1987-04-15 1988-04-15 Verfahren zur Produktion eines menschlichen, einkettigen Plasminogenaktivators

Country Status (18)

Country Link
US (1) US5175105A (fi)
EP (1) EP0288435B1 (fi)
JP (1) JP2894696B2 (fi)
AT (1) ATE102994T1 (fi)
AU (1) AU604305B2 (fi)
CA (1) CA1341306C (fi)
DD (1) DD274053A5 (fi)
DE (1) DE3888386T2 (fi)
DK (1) DK203588A (fi)
ES (1) ES2061719T3 (fi)
FI (1) FI98219C (fi)
HU (1) HU204557B (fi)
IL (1) IL86058A (fi)
MX (1) MX168507B (fi)
MY (1) MY103358A (fi)
NO (1) NO179046C (fi)
NZ (1) NZ224243A (fi)
PT (1) PT87230B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2634495B1 (fr) * 1988-07-01 1990-10-26 Chambon Pierre Procede de preparation d'une proteine par des levures utilisant un systeme inductible, vecteurs et souches transformees correspondantes
DE69034013T2 (de) * 1989-03-06 2003-07-31 Univ Texas Serpin-resistenter T-PA; Mutanten; Gene
US5866413A (en) * 1989-03-06 1999-02-02 Board Of Regents Of The University Of Texas System Pai-1 mutants
EP0387380A1 (en) * 1989-03-17 1990-09-19 BEHRINGWERKE Aktiengesellschaft Mutants of urinary plasminogen activator, their production and use
US5268273A (en) * 1990-12-14 1993-12-07 Phillips Petroleum Company Pichia pastoris acid phosphatase gene, gene regions, signal sequence and expression vectors comprising same
GB2256197B (en) * 1991-05-31 1995-11-22 Ciba Geigy Ag Yeast as host for expression of heterologous glycosyl transferase enzymes
SE9201544L (sv) * 1991-05-31 1992-12-01 Ciba Geigy Ag Saett att framstaella glykosyltransferaser
JPH0823995A (ja) * 1994-07-14 1996-01-30 Green Cross Corp:The 宿主細胞由来のプロテアーゼで低分子化され得る蛋白質の製造方法
US20030113271A1 (en) * 1997-01-29 2003-06-19 University Technology Corporation Formulations for pulmonary delivery
US6207442B1 (en) * 1997-10-16 2001-03-27 Zymogenetics, Inc. Plasmid construction by homologous recombination

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4245051A (en) * 1978-03-30 1981-01-13 Rockefeller University Human serum plasminogen activator
US4558010A (en) * 1980-04-03 1985-12-10 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator and method of making plasminogen activator protein therefrom
US4370417A (en) * 1980-04-03 1983-01-25 Abbott Laboratories Recombinant deoxyribonucleic acid which codes for plasminogen activator
NL8003402A (nl) * 1980-06-11 1982-01-04 Leuven Res & Dev Vzw Nieuwe plasminogeen-activator en farmaceutisch preparaat met trombolytische werking.
US4775622A (en) * 1982-03-08 1988-10-04 Genentech, Inc. Expression, processing and secretion of heterologous protein by yeast
FI88932C (fi) * 1982-04-15 1993-07-26 Genentech Inc Framstaellning av funktionellt maenskligt urokinasprotein
AR241654A1 (es) * 1982-05-05 1992-10-30 Genentech Inc Procedimiento para producir activador de plasminogeno de tejido humano.
NZ207926A (en) * 1983-04-25 1988-04-29 Genentech Inc Use of yeast #a#-factor to assist in expression of proteins heterologus to yeast
US5010003A (en) * 1983-04-25 1991-04-23 Genentech, Inc. Use of yeast homologous signals to secrete heterologous proteins
EP0154272B1 (en) * 1984-02-27 1992-01-08 Green Cross Corporation Production of human urokinase
JPS60256385A (ja) * 1984-05-18 1985-12-18 イーライ・リリー・アンド・カンパニー 酵母においてヘテロローガスポリペプチドを効率よく発現するための方法、ベクターおよび形質転換体
JPS60248181A (ja) * 1984-05-23 1985-12-07 Shiseido Co Ltd 酵母発現ベクタ−
EP0174835A1 (en) * 1984-09-11 1986-03-19 The Upjohn Company Human tissue plasminogen activator and recombinant DNA compounds
WO1986004351A1 (en) * 1985-01-25 1986-07-31 Sagami Chemical Research Center Stabilized human prourokinase
US5219569A (en) * 1985-04-22 1993-06-15 Genentech, Inc. Protease resistant urokinase
FR2581652B1 (fr) * 1985-04-22 1989-12-22 Genentech Inc Nouveaux mutants de l'activateur tissulaire du plasminogene humain
FI100106B (fi) * 1986-12-05 1997-09-30 Novartis Ag Menetelmä plasminogeenin yksisäikeisen yhdistelmäaktivaattorin valmist amiseksi
DE19736137C1 (de) * 1997-08-20 1998-10-01 Daimler Benz Ag Verfahren zum Starten eines Verbrennungsmotors

Also Published As

Publication number Publication date
NO179046B (no) 1996-04-15
FI98219C (fi) 1997-05-12
HU204557B (en) 1992-01-28
FI881713A0 (fi) 1988-04-13
MX168507B (es) 1993-05-27
EP0288435B1 (en) 1994-03-16
DE3888386T2 (de) 1994-07-14
NO179046C (no) 1996-07-24
JPS63296689A (ja) 1988-12-02
EP0288435A1 (en) 1988-10-26
CA1341306C (en) 2001-10-23
FI98219B (fi) 1997-01-31
IL86058A0 (en) 1988-09-30
FI881713A (fi) 1988-10-16
NZ224243A (en) 1991-02-26
DK203588D0 (da) 1988-04-14
DE3888386D1 (de) 1994-04-21
PT87230B (pt) 1992-08-31
ATE102994T1 (de) 1994-04-15
ES2061719T3 (es) 1994-12-16
JP2894696B2 (ja) 1999-05-24
DK203588A (da) 1988-10-16
IL86058A (en) 1993-07-08
NO881615D0 (no) 1988-04-14
AU1462688A (en) 1988-10-20
AU604305B2 (en) 1990-12-13
MY103358A (en) 1993-06-30
NO881615L (no) 1988-10-17
US5175105A (en) 1992-12-29
HUT46360A (en) 1988-10-28
PT87230A (pt) 1988-05-01

Similar Documents

Publication Publication Date Title
EP0225286B1 (en) Modified fibrinolytic agents
FI86746C (fi) Foerfarande foer framstaellning av maensklig vaevnads-plasminogenaktivator (tpa) med hjaelp av saccharomyces cerevisiae -jaest och i foerfarandet anvaenda hybridvektorer
DD218118A5 (de) Verfahren zur herstellung eines hefe- oder nichthefepolypeptids
US5902735A (en) Functional DNA block and plasmid coding for hirudin, transformed yeast, method for hirudin, hirudin obtained, and its pharmaceutical use
EP0225633B1 (en) Production of thrombin inhibitors
IL90170A (en) Method and yeast strains lacking ACSY Carboxypeptidase activity that have been transformed to form non-C-terminal polypeptides
DE3537176A1 (de) Expression eines plasminogenaktivators in hefe
DD274053A5 (de) Verfahren zur Produktion eines menschlichen, einkettigen Plasminogenaktivators
DE69333249T2 (de) Neue Schimmel-Protease
US5217891A (en) DNA constructs containing a kluyveromyces α factor leader sequence for directing secretion of heterologous polypeptides
EP0408945A1 (de) Plasmide, deren Herstellung und deren Verwendung bei der Gewinnung eines Plasminogenaktivators
EP0421919A2 (en) Polygalacturonase encoding fungal expression system
EP1169461B1 (de) Verwendung von pankreatischer Procarboxypeptidase B zur Herstellung von Insulin
JPH01501996A (ja) 脱―表皮細胞成長因子プラスミノーゲンアクチベーター
EP0496327B1 (de) Verfahren zur Herstellung von Polypeptiden mit Prourokinase-Aktivität
FI96121B (fi) DNA-rakenne ja menetelmä heterologisen proteiinin tuottamiseksi
US6410272B1 (en) Production of thrombin inhibitors
JP3226289B2 (ja) 分泌ベクター、該ベクターで形質転換した微生物及び該微生物から産生される産物の製造法
KR970001564B1 (ko) 우로키나제-형 플라스미노겐 활성체
KR0179653B1 (ko) 진균 발현 시스템
IE61775B1 (en) Process for the production of proteins
DD255170A5 (de) Verfahren zur Herstellung von proteinen mit Hirudinaktivität
DD283839A5 (de) Verfahren zur herstellung eines hefestammes ohne carboxyteptidase-ysc alpha-aktivitaet

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee